Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00772473 · ClinicalTrials.gov registry record
Correlation of Calcitonin Gene-Related Peptide (CGRP) Levels in Saliva With the Evolution of an Attack of Migraine
A clinical trial, sponsored by Clinvest.
- Completed
- Registry status
- 34
- Enrollment target
NCT00772473: Completed study, sponsored by Clinvest.
NCT00772473 is a clinical trial that has completed, run by Clinvest. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00772473 has completed, sponsored by Clinvest.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
To assess CGRP levels in saliva through the evolution of migraine.
Interventions
- OTHER subjects personal triptan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2008-02 |
| Est. Completion | 2009-01 |
What the finished NCT00772473 record still lists
NCT00772473 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which subjects personal triptan is the first listed.
NCT00772473 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00772473 about?
NCT00772473 is a clinical study titled "Correlation of Calcitonin Gene-Related Peptide (CGRP) Levels in Saliva With the Evolution of an Attack of Migraine". To assess CGRP levels in saliva through the evolution of migraine.
What is the current status of trial NCT00772473?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2008-02. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00772473?
The interventions under investigation include: subjects personal triptan (OTHER).
Who is sponsoring clinical trial NCT00772473?
This trial is sponsored by Clinvest, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia